Table 3.
Univariate and multivariate analyses of the associations between HGSOC Patient Risk Factors.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| MAP3K3 (low vs overexpression) | 1.001 | 0.997–1.004 | 0.655 | 0.998 | 0.990–1.007 | 0.699 |
| Age (≤50 y vs > 50 y) | 0.999 | 0.960–1.038 | 0.947 | 1.020 | 0.932–1.115 | 1.020 |
| FIGO stage (I-II vs III-IV) | 1.931 | 1.197–3.115 | 0.007** | 3.918 | 1.096–13.999 | 0.036* |
| Ascites (no vs yes) | 1.094 | 0.349–3.432 | 0.878 | 1.247 | 0.100–15.532 | 0.864 |
| Chemotherapy response (sensitive vs partial) | 7.788 | 2.572–23.578 | 0.000*** | 13.129 | 0.899–191.787 | 0.060 |
Abbreviations: HR, hazard ratio; CI, confidence interval.